Ignite Creation Date:
2025-12-25 @ 2:03 AM
Ignite Modification Date:
2025-12-26 @ 12:28 AM
Study NCT ID:
NCT03518060
Status:
COMPLETED
Last Update Posted:
2024-10-16
First Post:
2018-04-26
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dolutegravir/Rilpivirine, Antiretroviral Efficacy Study Using Real-world Data in Subjects With Human Immunodeficiency Virus (HIV)-1
Sponsor:
ViiV Healthcare
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-06-25
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-14
Completion Date Type:
ACTUAL
First Submit Date:
2018-04-26
First Submit QC Date:
None
Study First Post Date:
2018-05-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-05-13
Results First Submit QC Date:
None
Results First Post Date:
2024-10-16
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-10-11
Last Update Post Date:
2024-10-16
Last Update Post Date Type:
ACTUAL